Hangzhou Jiuyuan Gene Engineering (HKG:2566) board has proposed to change the English name of the company to "Hangzhou Jiuyuan Genetic Biopharmaceutical," according to a Wednesday filing with the Hong Kong bourse.
The board also wants to change the company's Chinese name and amend the articles of association.
All changes must be approved by the stakeholders during an extraordinary general meeting (EGM).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.